My thought is because that is what the American Association for the Study of Liver Disease Recommendations for Testing, Managing,
and Treating Hepatitis C recommends for the treatment of Genotype 1 treatment naive non-cirrotics who are eligible for interferon.
http://www.hcvguidelines.org/sites/default/files/full_report.pdf
based on the NEUTRINO clinical trial results
Also that is per the prescribing information on label usage on the Sovaldi prescribing insert the little paper that shouild accompany the prescription.
http://www.gilead.com/~/media/Files/pdfs/medicines/liver-disease/sovaldi/sovaldi_pi.pdf
again this is based on the NEUTRINO clinical trial results as well.
The Sovaldi Olysio with or without Ribavirin is the recommended treatment for interferon ineligible patients like for example me because I have cirrhosis and also have failed interferon based treatment 3 times as a null responder. Of course the Solvaldi Olysio is off label as they are not intended to be used together but the COSMOS trial showed good efficacy for these types of patients. Of course being off label can make it more challenging to get this prescribed although many here have been successful getting this combination as we have seen.
So that's my 2 cents
Lynn
That's a question I have wondered about myself. I am sure there are different opinions and I don't know if any are in stone. I was waiting to see if anyone else expressed an opinion before I replied but figured I would go ahead. I am Genotype 1a. no cirrhosis like you and was prescribed Sovaldi and Olysio only for 12 weeks. I told my doctor I did not want to take Ribavirin or anything else with these two others. He said okay but didn't think I would be approved. Surprising to the doctor and myself I was approved. The doctor said the main treatment drug is Sovaldi and the Olysio is prescribed with it due to the drug maker not wanting Sovaldi to ever be prescribed alone. I think it is possible that with all three the possibility of SVR is more likely, not sure. I hope someone else has an idea here.